BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6367984)

  • 1. A pancreatic oncofetal antigen (POA): its characterization and application for enzyme immunoassay.
    Oguchi H; Homma T; Kawa S; Nagata A; Furuta S; Fukui H
    Cancer Detect Prev; 1984; 7(1):51-8. PubMed ID: 6367984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pancreatic oncofetal antigen (POA)].
    Mugitani H; Furue H; Kako M; Hirota F; Fuse K; Takahashi T; Sakamoto K; Yamada K; Suminaga M; Ezaki M; Judo R
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1737-43. PubMed ID: 6882002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of pancreatic oncofetal antigen (POA) in the diagnosis of pancreatic cancer].
    Nishida K
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):601-8. PubMed ID: 6349542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pancreatic oncofetal antigen (POA)--its characterization and the result of enzyme immunoassay].
    Homma T
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):617-22. PubMed ID: 6349543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pancreatic oncofetal antigen (POA) and carcinoma of the pancreas].
    Homma T; Oguchi H; Kawa S; Nagata A; Furuta S
    Gan No Rinsho; 1984 May; 30(6 Suppl):558-62. PubMed ID: 6205174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of pancreatic cancer by pancreatic oncofetal antigen (poa) in pure pancreatic juice.
    Nishida K; Kondo M; Jessen K; Classen M
    Hepatogastroenterology; 1981 Apr; 28(2):102-5. PubMed ID: 7216142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme immunoassay of pancreatic oncofetal antigen (POA) as a marker of pancreatic cancer.
    Nishida K; Sugiura M; Yoshikawa T; Kondo M
    Gut; 1985 May; 26(5):450-5. PubMed ID: 3888788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic usefulness of serum levels of pancreatic oncofetal antigen (POA) and CA 19-9 in pancreatic cancers: monitoring of postoperative recurrences].
    Takami H; Hishinuma S; Shintoku J; Ogata Y; Abe O
    Gan No Rinsho; 1985 May; 31(6 Suppl):631-7. PubMed ID: 3861883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical application of the enzyme immunoassay for pancreatic oncofetal antigen.
    Kawa S; Homma T; Oguchi H; Nagata A; Furuta S; Usuda N; Nagata T; Fukui H
    Ann N Y Acad Sci; 1983; 417():400-9. PubMed ID: 6367597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tumor markers of pancreatic cancer].
    Takami H; Hishinuma S; Shintoku J; Furuuchi T; Ogata Y; Abe O
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):212-9. PubMed ID: 3855615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on a pancreatic oncofetal antigen (POA) in patients with pancreatic cancer].
    Hishnuma S
    Nihon Geka Gakkai Zasshi; 1986 Nov; 87(11):1449-60. PubMed ID: 3785134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue polypeptide antigen, galactosyltransferase isoenzyme II and pancreatic oncofetal antigen serum determination: role in pancreatic cancer diagnosis.
    Basso D; Fabris C; Panucci A; Del Favero G; Angonese C; Plebani M; Petrin P; Burlina A; Naccarato R
    Int J Pancreatol; 1988; 3 Suppl 1():S95-100. PubMed ID: 3145303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pancreatic cancer-related antigen (PCAA) and pancreatic tissue antigen (PaA)--their chemical compositions, tissue localization, and clinical significance].
    Shimano T; Mori T; Maruyama H; Kitada M; Kosaki G
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):609-16. PubMed ID: 6881993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of serum DU-PAN-2 surveyed by solid-phase sandwich EIA for DU-PAN-2].
    Ishii M; Urabe T; Seino Y
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1860-5. PubMed ID: 3296960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated pancreatic oncofetal antigen levels measured by enzyme immunoassay in pure pancreatic juice of patients with pancreatic cancer.
    Nishida K; Yoshikawa T; Fukumoto K; Kondo M
    Oncology; 1986; 43(5):311-5. PubMed ID: 3531954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of carbohydrate antigen (CA) 19-9 levels in pure pancreatic juice of patients with pancreatic cancer.
    Nishida K; Tasaki N; Miyagawa H; Yoshikawa T; Kondo M
    Am J Gastroenterol; 1988 Feb; 83(2):126-9. PubMed ID: 3422536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antigens in the blood serum in pancreatic cancer].
    Vel'bri SK
    Vopr Onkol; 1979; 25(11):28-31. PubMed ID: 516561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of serum DU-PAN-2 by enzyme immunoassay in patients with various digestive cancers].
    Takemori Y; Sawabu N; Satomura Y; Ohta H; Watanabe H; Okai T; Mai M; Hattori N; Akiyama T; Hashimoto T
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):119-26. PubMed ID: 3541791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of enzyme immunoassay for a pancreatic oncofetal antigen (POA)].
    Hishinuma S; Takami H; Shintoku J; Matsui J; Uematsu S; Baba H; Ogata Y; Abe O; Ishii T; Miyoshi K
    Nihon Gan Chiryo Gakkai Shi; 1984 Dec; 19(10):2217-24. PubMed ID: 6398349
    [No Abstract]   [Full Text] [Related]  

  • 20. [Occurrence of pancreatic tumor markers and diagnosis of small pancreatic tumors. 3). POA (pancreatic oncofetal antigen)].
    Kawa S; Oguchi H; Homma T
    Nihon Rinsho; 1986 Aug; 44(8):1821-4. PubMed ID: 3537373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.